ArticlemAbs2025

Preclinical pharmacology, pharmacokinetics, and pharmacodynamics of veligrotug, a full antagonist antibody to the IGF-1 receptor in development for thyroid eye disease.

Rachel Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.